415 related articles for article (PubMed ID: 31737580)
1. Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers.
Sanaei M; Kavoosi F
Adv Biomed Res; 2019; 8():63. PubMed ID: 31737580
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma.
Sanaei M; Kavoosi F
Iran J Pharm Res; 2021; 20(3):324-336. PubMed ID: 34903992
[TBL] [Abstract][Full Text] [Related]
3. Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.
Zhou M; Yuan M; Zhang M; Lei C; Aras O; Zhang X; An F
Eur J Med Chem; 2021 Dec; 226():113825. PubMed ID: 34562854
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylases function as novel potential therapeutic targets for cancer.
Zhang H; Shang YP; Chen HY; Li J
Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of HDACs--effective drugs against cancer?
Müller S; Krämer OH
Curr Cancer Drug Targets; 2010 Mar; 10(2):210-28. PubMed ID: 20201785
[TBL] [Abstract][Full Text] [Related]
6. The application of histone deacetylases inhibitors in glioblastoma.
Chen R; Zhang M; Zhou Y; Guo W; Yi M; Zhang Z; Ding Y; Wang Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):138. PubMed ID: 32682428
[TBL] [Abstract][Full Text] [Related]
7. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas.
Manta A; Kazanas S; Karamaroudis S; Gogas H; Ziogas DC
Oncol Res; 2022; 30(5):211-219. PubMed ID: 37305348
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of histone deacetylase inhibitors in cancer development and therapeutic potential.
Zhang C; Li HX; Man Y; Jiang ZH; Yin P; Yu K
J Physiol Pharmacol; 2024 Apr; 75(2):117-122. PubMed ID: 38736259
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Li QQ; Hao JJ; Zhang Z; Hsu I; Liu Y; Tao Z; Lewi K; Metwalli AR; Agarwal PK
Int J Oncol; 2016 Jun; 48(6):2591-607. PubMed ID: 27082124
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents.
Cappellacci L; Perinelli DR; Maggi F; Grifantini M; Petrelli R
Curr Med Chem; 2020; 27(15):2449-2493. PubMed ID: 30332940
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors as cancer therapeutics.
Clawson GA
Ann Transl Med; 2016 Aug; 4(15):287. PubMed ID: 27568481
[TBL] [Abstract][Full Text] [Related]
13. Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies.
Pal D; Raj K; Nandi SS; Sinha S; Mishra A; Mondal A; Lagoa R; Burcher JT; Bishayee A
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345145
[TBL] [Abstract][Full Text] [Related]
14. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
15. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
Verza FA; Das U; Fachin AL; Dimmock JR; Marins M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
Emanuele S; Lauricella M; Tesoriere G
Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
[TBL] [Abstract][Full Text] [Related]
17. Role of histone deacetylase inhibitors in the treatment of cancer (Review).
Mei S; Ho AD; Mahlknecht U
Int J Oncol; 2004 Dec; 25(6):1509-19. PubMed ID: 15547685
[TBL] [Abstract][Full Text] [Related]
18. Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma.
Phimmachanh M; Han JZR; O'Donnell YEI; Latham SL; Croucher DR
Front Cell Dev Biol; 2020; 8():578770. PubMed ID: 33117806
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors: insights into mechanisms of lethality.
Rosato RR; Grant S
Expert Opin Ther Targets; 2005 Aug; 9(4):809-24. PubMed ID: 16083344
[TBL] [Abstract][Full Text] [Related]
20. Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency.
Pan Y; Hou H; Zhou B; Gao J; Gao F
Eur J Med Chem; 2023 Dec; 262():115879. PubMed ID: 37875056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
